Breadcrumb Home investors intimation stock exchanges Intimation to stock Exchanges Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-20182016-20172015-20162014-20152013-20142012-20132011-20122010-2011 Apply Schedule of Analyst Institutional Investor Meetings 04th Feb 2022 Resignation of Ms. Naina Lal Kidwai, Independent Director 26th Jan 2022 Slump Sale of Business Undertakings 25th Jan 2022 Outcome of Board Meeting – 25th January 2022 25th Jan 2022 Transcript Of The 40th Annual J.P. Morgan Healthcare Conference 17th Jan 2022 Earning Conference call schedule on 25th January 2022 17th Jan 2022 Reconciliation of Share Capital Audit Report 15th Jan 2022 Allotment of 20,736 equity shares under ESOS 2013-A 14th Jan 2022 Press Release ‐ Cipla wins the prestigious Frost & Sullivan and TERI’s Sustainability 4.0 Award 2021 as “Challenger in Mega Large Business Pharma Sector” 13th Jan 2022 Update on intimation dated 3rd November, 2021 on termination of Stock Purchase and Merger Agreement (“the SPMA”) with Avenue Therapeutics Inc. 12th Jan 2022 Pagination First page first Previous page ‹ Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Next page › Last page last BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.